• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 大流行期间心脏植入式电子设备随访的管理:意大利封锁期间的经验教训。

Management of cardiac implantable electronic device follow-up in COVID-19 pandemic: Lessons learned during Italian lockdown.

机构信息

Department of Cardiovascular, Respiratory, Nephrology, Anaesthesiology and Geriatric Sciences, "Sapienza" University of Rome, Rome, Italy.

Texas Cardiac Arrhythmia Institute, St David's Medical Center, Austin, Texas, USA.

出版信息

J Cardiovasc Electrophysiol. 2020 Nov;31(11):2814-2823. doi: 10.1111/jce.14755. Epub 2020 Sep 30.

DOI:10.1111/jce.14755
PMID:32954600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7646650/
Abstract

INTRODUCTION

Remote monitoring (RM) has significantly transformed the standard of care for patients with cardiac electronic implantable devices. It provides easy access to valuable information, such as arrhythmic events, acute decompensation manifestations and device-related issues, without the need of in-person visits.

METHODS

Starting March 1st, 332 patients were introduced to an RM program during the Italian lockdown to limit the risk of in-hospital exposure to severe acute respiratory syndrome-coronavirus-2. Patients were categorized into two groups based on the modality of RM delivery (home [n = 229] vs. office [n = 103] delivered). The study aimed at assessing the efficacy of the new follow-up protocol, assessed as mean RM activation time (AT), and the need for technical support. In addition, patients' acceptance and anxiety status were quantified via the Home Monitoring Acceptance and Satisfaction Questionnaire and the Generalized Anxiety Disorder 7-item scale.

RESULTS

AT time was less than 48 h in 93% of patients and 7% of them required further technical support. Despite a higher number of trans-telephonic technical support in the home-delivered RM group, mean AT was similar between groups (1.33 ± 0.83 days in home-delivered vs 1.28 ± 0.81 days in office-delivered patients; p = .60). A total of 28 (2.5%) urgent/emergent in-person examinations were required. A high degree of patient satisfaction was reached in both groups whereas anxiety status was higher in the office-delivered group.

CONCLUSIONS

The adoption of RM resulted in high patient satisfaction, regardless of the modality of modem delivery; nonetheless, in-office modem delivery was associated with a higher prevalence of anxiety symptoms.

摘要

简介

远程监测(RM)显著改变了心脏电子植入设备患者的护理标准。它提供了方便获取有价值信息的途径,如心律失常事件、急性失代偿表现和与设备相关的问题,而无需进行面对面的就诊。

方法

从 3 月 1 日起,为了限制因严重急性呼吸综合征冠状病毒 2 而在医院暴露的风险,332 名患者开始参与一个 RM 计划。患者根据 RM 传递方式(家庭[ n = 229]与办公室[ n = 103])分为两组。该研究旨在评估新的随访方案的效果,评估指标为平均 RM 激活时间(AT)和对技术支持的需求。此外,通过家庭监测接受和满意度问卷和广泛性焦虑障碍 7 项量表来量化患者的接受程度和焦虑状况。

结果

93%的患者的 AT 时间小于 48 小时,其中 7%的患者需要进一步的技术支持。尽管家庭传递 RM 组需要更多的电话技术支持,但两组的平均 AT 相似(家庭传递组为 1.33±0.83 天,办公室传递组为 1.28±0.81 天; p = 0.60)。总共需要 28 次(2.5%)紧急/紧急的当面检查。两组患者均达到了较高的满意度,而办公室传递组的焦虑状况较高。

结论

无论传递方式如何,采用 RM 均可获得较高的患者满意度;然而,在办公室传递方式下,焦虑症状的发生率更高。

相似文献

1
Management of cardiac implantable electronic device follow-up in COVID-19 pandemic: Lessons learned during Italian lockdown.COVID-19 大流行期间心脏植入式电子设备随访的管理:意大利封锁期间的经验教训。
J Cardiovasc Electrophysiol. 2020 Nov;31(11):2814-2823. doi: 10.1111/jce.14755. Epub 2020 Sep 30.
2
Remote monitoring of cardiac implantable electronic devices (CIED).心脏植入式电子设备(CIED)的远程监测
Trends Cardiovasc Med. 2016 Aug;26(6):568-77. doi: 10.1016/j.tcm.2016.03.012. Epub 2016 Mar 31.
3
Effectiveness of remote monitoring of CIEDs in detection and treatment of clinical and device-related cardiovascular events in daily practice: the HomeGuide Registry.远程监测 CIED 在日常实践中检测和治疗临床及器械相关心血管事件的效果:HomeGuide 注册研究。
Europace. 2013 Jul;15(7):970-7. doi: 10.1093/europace/eus440. Epub 2013 Jan 29.
4
Effects of remote monitoring of cardiac implantable electronic devices after stroke or transient ischemic attack.心脏植入式电子设备远程监测在卒中和短暂性脑缺血发作后的效果。
J Cardiovasc Med (Hagerstown). 2019 Aug;20(8):551-556. doi: 10.2459/JCM.0000000000000822.
5
Analysis of arrhythmic events is useful to detect lead failure earlier in patients followed by remote monitoring.分析心律失常事件有助于在接受远程监测的患者中更早地发现导联故障。
J Cardiovasc Electrophysiol. 2018 Mar;29(3):463-470. doi: 10.1111/jce.13399. Epub 2017 Dec 18.
6
Intrahospital organizational model of remote monitoring data sharing, for a global management of patients with cardiac implantable electronic devices: a document of the Italian Association of Arrhythmology and Cardiac Pacing.院内远程监测数据共享的组织模式,用于心脏植入式电子设备患者的全球管理:意大利心律失常学和心脏起搏协会文件。
J Cardiovasc Med (Hagerstown). 2020 Mar;21(3):171-181. doi: 10.2459/JCM.0000000000000912.
7
Implementation and reimbursement of remote monitoring for cardiac implantable electronic devices in Europe: a survey from the health economics committee of the European Heart Rhythm Association.欧洲心脏节律协会卫生经济学委员会关于欧洲心脏植入式电子设备远程监测的实施与报销情况调查
Europace. 2015 May;17(5):814-8. doi: 10.1093/europace/euu390. Epub 2015 Feb 20.
8
Long-term patient satisfaction with implanted device remote monitoring: a comparison among different systems.长期患者对植入式设备远程监测的满意度:不同系统的比较。
J Cardiovasc Med (Hagerstown). 2019 Aug;20(8):542-550. doi: 10.2459/JCM.0000000000000818.
9
Mobile health and implantable cardiac devices: Patients' expectations.移动医疗和植入式心脏设备:患者的期望。
Eur J Prev Cardiol. 2019 Jun;26(9):920-927. doi: 10.1177/2047487319830531. Epub 2019 Mar 1.
10
Impact of COVID-19 lockdown in patients with implantable cardioverter and cardiac resynchronization therapy defibrillators: insights from daily remote monitoring transmissions.COVID-19 封锁对植入式心脏转复除颤器和心脏再同步治疗除颤器患者的影响:来自日常远程监测传输的见解。
Heart Vessels. 2021 Nov;36(11):1694-1700. doi: 10.1007/s00380-021-01843-w. Epub 2021 Mar 29.

引用本文的文献

1
Challenging the status quo: a scoping review of value-based care models in cardiology and electrophysiology.挑战现状:心脏学和电生理学中基于价值的护理模式的范围综述。
Europace. 2024 Aug 30;26(9). doi: 10.1093/europace/euae210.
2
Co-Management of COVID-19 and Heart Failure During the COVID-19 Pandemic: Lessons Learned.2019冠状病毒病大流行期间2019冠状病毒病与心力衰竭的共同管理:经验教训
Rev Cardiovasc Med. 2022 Jun 16;23(6):218. doi: 10.31083/j.rcm2306218. eCollection 2022 Jun.
3
Informational Postcards Increase Engagement with Remote Monitoring Among Veterans with Pacemakers and Implantable Cardioverter-Defibrillators: a Stepped-Wedge Randomized Controlled Trial.信息明信片可提高起搏器和植入式心律转复除颤器退伍军人对远程监测的参与度:一项阶梯楔形随机对照试验。
J Gen Intern Med. 2024 Feb;39(Suppl 1):87-96. doi: 10.1007/s11606-023-08478-9. Epub 2024 Jan 22.
4
Patient-reported experiences and outcomes of virtual care during COVID-19: a systematic review.新冠疫情期间虚拟护理的患者报告体验和结果:系统评价。
J Patient Rep Outcomes. 2023 Dec 1;7(1):126. doi: 10.1186/s41687-023-00659-8.
5
Telemedicine: an Effective and Low-Cost Lesson From the COVID-19 Pandemic for the Management of Heart Failure Patients.远程医疗:COVID-19 大流行期间管理心力衰竭患者的有效且低成本的经验教训。
Curr Heart Fail Rep. 2023 Oct;20(5):382-389. doi: 10.1007/s11897-023-00624-y. Epub 2023 Sep 4.
6
Remote Management of Patients with Cardiac Implantable Electronic Devices during the COVID-19 Pandemic.2019年冠状病毒病大流行期间心脏植入式电子设备患者的远程管理
J Cardiovasc Dev Dis. 2023 May 14;10(5):214. doi: 10.3390/jcdd10050214.
7
HeartLogic™: real-world data-efficiency, resource consumption, and workflow optimization.心脏逻辑™:真实世界的数据效率、资源消耗及工作流程优化。
Eur Heart J Suppl. 2023 Apr 26;25(Suppl C):C331-C336. doi: 10.1093/eurheartjsupp/suad058. eCollection 2023 May.
8
The Feasibility, Effectiveness and Acceptance of Virtual Visits as Compared to In-Person Visits among Clinical Electrophysiology Patients during the COVID-19 Pandemic.2019年冠状病毒病大流行期间,临床电生理患者虚拟就诊与面对面就诊相比的可行性、有效性和可接受性
J Clin Med. 2023 Jan 12;12(2):620. doi: 10.3390/jcm12020620.
9
The evolution of digital health technologies in cardiovascular disease research.心血管疾病研究中数字健康技术的发展
NPJ Digit Med. 2023 Jan 3;6(1):1. doi: 10.1038/s41746-022-00734-2.
10
Impact of remote monitoring in heart failure patients with cardiac implantable electronic devices during COVID-19 pandemic: a single center experience.COVID-19 大流行期间使用心脏植入式电子设备的心力衰竭患者远程监测的影响:单中心经验。
J Cardiothorac Surg. 2022 Aug 28;17(1):213. doi: 10.1186/s13019-022-01963-y.

本文引用的文献

1
Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy.意大利北部新冠疫情期间急性冠状动脉综合征住院率降低
N Engl J Med. 2020 Jul 2;383(1):88-89. doi: 10.1056/NEJMc2009166. Epub 2020 Apr 28.
2
Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association.COVID-19 大流行期间心脏电生理学的指南:心律学会 COVID-19 工作组;美国心脏病学会电生理学分会;美国心脏协会临床心脏病学理事会心电图和心律失常委员会。
Heart Rhythm. 2020 Sep;17(9):e233-e241. doi: 10.1016/j.hrthm.2020.03.028. Epub 2020 Apr 1.
3
Feasibility of automated detection of sleep apnea using implantable pacemakers and defibrillators: a comparison with simultaneous polysomnography recording.使用植入式起搏器和除颤器自动检测睡眠呼吸暂停的可行性:与同步多导睡眠图记录的比较
J Interv Card Electrophysiol. 2019 Dec;56(3):327-333. doi: 10.1007/s10840-019-00631-x. Epub 2019 Oct 23.
4
Long-term patient satisfaction with implanted device remote monitoring: a comparison among different systems.长期患者对植入式设备远程监测的满意度:不同系统的比较。
J Cardiovasc Med (Hagerstown). 2019 Aug;20(8):542-550. doi: 10.2459/JCM.0000000000000818.
5
A Multisensor Algorithm Predicts Heart Failure Events in Patients With Implanted Devices: Results From the MultiSENSE Study.多传感器算法预测植入设备患者的心力衰竭事件:MultiSENSE 研究结果。
JACC Heart Fail. 2017 Mar;5(3):216-225. doi: 10.1016/j.jchf.2016.12.011.
6
Further evidence that remote monitoring is cost-effective: It's time for all to adopt.远程监测具有成本效益的进一步证据:是时候让所有人都采用了。
Heart Rhythm. 2017 Jan;14(1):58. doi: 10.1016/j.hrthm.2016.09.023. Epub 2016 Sep 23.
7
Novel perspectives on arrhythmia-induced cardiomyopathy: pathophysiology, clinical manifestations and an update on invasive management strategies.心律失常性心肌病的新观点:病理生理学、临床表现及侵入性治疗策略的最新进展
Cardiol Rev. 2015 May-Jun;23(3):135-41. doi: 10.1097/CRD.0000000000000040.
8
Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial.基于植入物的心力衰竭患者多参数远程监测(IN-TIME):一项随机对照试验。
Lancet. 2014 Aug 16;384(9943):583-590. doi: 10.1016/S0140-6736(14)61176-4.
9
Device monitoring of heart failure in cardiac resynchronization therapy device recipients: a single-center experience with a novel multivector impedance monitoring system.心脏再同步治疗患者心力衰竭的器械监测:新型多向量阻抗监测系统的单中心经验。
J Cardiovasc Med (Hagerstown). 2013 Oct;14(10):726-32. doi: 10.2459/JCM.0b013e3283650587.
10
Workflow, time and patient satisfaction from the perspectives of home monitoring.从家庭监测的角度来看工作流程、时间和患者满意度。
Europace. 2013 Jun;15 Suppl 1:i49-i53. doi: 10.1093/europace/eut113.